(S)-Methyl 2-(3-Amino-4-((S)-2-amino-3-(4-hydroxyphenyl)-propanamido)benzamido)-3-(4-hydroxyphenyl)propanoate

ID: ALA3416715

Chembl Id: CHEMBL3416715

PubChem CID: 118734282

Max Phase: Preclinical

Molecular Formula: C26H28N4O6

Molecular Weight: 492.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccc(NC(=O)[C@@H](N)Cc2ccc(O)cc2)c(N)c1

Standard InChI:  InChI=1S/C26H28N4O6/c1-36-26(35)23(13-16-4-9-19(32)10-5-16)30-24(33)17-6-11-22(20(27)14-17)29-25(34)21(28)12-15-2-7-18(31)8-3-15/h2-11,14,21,23,31-32H,12-13,27-28H2,1H3,(H,29,34)(H,30,33)/t21-,23-/m0/s1

Standard InChI Key:  MMHWDEYTWTZRBI-GMAHTHKFSA-N

Alternative Forms

  1. Parent:

    ALA3416715

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNPEP Tchem Cystinyl aminopeptidase (313 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 492.53Molecular Weight (Monoisotopic): 492.2009AlogP: 1.70#Rotatable Bonds: 9
Polar Surface Area: 177.00Molecular Species: NEUTRALHBA: 8HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 8#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.22CX Basic pKa: 8.00CX LogP: 1.72CX LogD: 1.28
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.19Np Likeness Score: -0.20

References

1. Papakyriakou A, Zervoudi E, Tsoukalidou S, Mauvais FX, Sfyroera G, Mastellos DC, van Endert P, Theodorakis EA, Vourloumis D, Stratikos E..  (2015)  3,4-diaminobenzoic acid derivatives as inhibitors of the oxytocinase subfamily of M1 aminopeptidases with immune-regulating properties.,  58  (3): [PMID:25635706] [10.1021/jm501867s]

Source